🇺🇸 FDA
Pipeline program

DOBUTAMINE , LEVOSIMENDAN

LEVOMEMS

Approved small_molecule active

Quick answer

DOBUTAMINE , LEVOSIMENDAN for Heart failure patients with depressed left ventricular ejection fraction is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Heart failure patients with depressed left ventricular ejection fraction
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials